Navigation Links
Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function

ion, graft loss, death, and the percent change in measured GFR.

After 12 months of follow-up, investigators found acute rejection in 6.1% of patients in the CellCept and sirolimus group, compared to 7.3% of patients in the CellCept and CNI group. Graft loss was experienced by 2.0% of patients in the CellCept and sirolimus group, compared to 3.6% of patients in the CellCept and CNI group.

None of the patients in the CellCept and sirolimus group died, while one patient death was remotely related to the CellCept and CNI group. Patients in the CellCept and sirolimus group had a median 18.5% increase from baseline in GFR, compared to a median 4.4% decrease in the CellCept and CNI group. Safety outcomes were similar in both groups.

Optimizing use of immunosuppressants for achieving long-term success is the primary focus of these clinical trials. Kidney STN, liver STN and OptiCept are all studying CellCept with the goal of reducing CNI associated nephrotoxicity therapy to prolong graft and patient survival. Final results of this study, which will be available later this year, will provide more definitive conclusions about the long-term effect of these regimens on renal function.

About CellCept

CellCept is an immunosuppressant or anti-rejection drug approved for use in combination with other immunosuppressive drugs (cyclosporine and corticosteroids) for the prevention of rejection in patients receiving kidney, heart and liver transplants.

There are no adequate and well-controlled studies in pregnant women. As CellCept has been shown to have teratogenic effects in animals at subclinical doses on a body surface area basis, it may cause fetal harm when administered to a pregnant woman. CellCept should not be used in pregnant women unless the potential benefit justifies the potential risk to the fetus. Women of childbearing potential should have a negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL within one
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
4. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
5. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
6. Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data
7. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
8. Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron
9. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
10. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
11. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
Post Your Comments:
(Date:12/15/2009)... At today,s regular meeting of the board of directors ... the board declared a regular quarterly dividend of 31 ... of record at the close of business on February ... ,, The Lubrizol Corporation (NYSE: LZ ) ... supplies technologies that improve the quality and performance of ...
(Date:12/15/2009)... Mass., Dec. 15 NxStage Medical, Inc. ... innovative dialysis products, today announced that a group ... will be embarking on a week-long, conventional (non-dialysis) ... The cruise, dubbed the "2010 Freedom Cruise: ... Miami, Fla. on January 3, 2010 and returns ...
(Date:12/15/2009)... 15 Varian Medical Systems (NYSE: ... for first quarter of fiscal year 2010 following the ... The news release will be followed by a ... PT. The news release and a link to ... company website at: www.varian.com/investor . To access ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Military children face more emotional challenges as parental deployments grow longer study finds 62694 1Military children face more emotional challenges as parental deployments grow longer study finds 62694 2Military children face more emotional challenges as parental deployments grow longer study finds 62694 3Recognized Top Performers in UHC Supply Chain 62691 1Recognized Top Performers in UHC Supply Chain 62691 2FDA CDC and States Investigating Norovirus Illnesses Linked to Oysters 62689 1FDA CDC and States Investigating Norovirus Illnesses Linked to Oysters 62689 2
... 2007 /PRNewswire-FirstCall/ -- Bioponic,Phytoceuticals, Inc. ("Bioponic" or ... Bioresonant Phytotherapeutic(R) form of,Turmeric containing curcumin in ... important treatment for Lung Cancer. , In ... "Induction of,Apoptosis in Human Lung Cancer Cells ...
... -- Afid,Therapeutics, Inc. announced that it received positive ... viral sequestration agents to,block viral infections of mammalian ... independent third party testing,organization. The new viral sequestrating ... 3 critical mechanisms thus blocking,infection. They are aimed ...
Other Medicine Technology:Curecumin May Be an Effective Treatment for Lung Cancer 2Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
(Date:12/15/2009)... of the U.S. Senate to allow importation of ... more effective direct bulk purchasing of prescription drugs, ... industry controls the health reform debate, according Consumer ... Dorgan (D-ND) was a relatively modest proposal, far ... to directly negotiate discounts with drug manufacturers," said ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security company, today ... Series next-generation firewalls for accurate threat prevention on ... control over applications such as peer-to-peer file sharing. ... with eight facilities on five campuses. The university ... of academic schools and institutions throughout Japan. It ...
(Date:12/15/2009)... of reproductive age were evaluated, Italian study found , , ... children born with cystic fibrosis decreases when screening for ... a new study finds. , CF neonatal screening has ... many years. Since the 1990s, the area has seen ... born with CF. , Two different CF carrier detection ...
(Date:12/15/2009)... Prostate cancer tests promised but not delivered ... Network calls on Congress to ensure that healthcare ... benefit currently required of insurance companies in 37 ... for those segments of the population and individuals ... American men and men who have a family ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2
... BlueCross BlueShield of South,Carolina announced today that ... URAC, a Washington, D.C.-based health care accrediting,organization ... care,industry. URAC,s Case Management Accreditation standards ... plan and implement case management,interventions. "BlueCross ...
... 20 Governor Edward G.,Rendell today signed House Bill 191 ... people who are 16 years old to donate blood as ... Before Governor Rendell signed the bill, people could not ... blood banks asked for,the change to compensate for a population ...
... produced in the obese may so dilute levels of a ... may be essentially useless for diagnosing prostate cancer in men ... the American Medical Association suggests. , The new ... at The Johns Hopkins Hospital and elsewhere, could eventually affect ...
... boosts survival of very sick children, study finds , , ... response team of experts at a children,s hospital can ... arrests outside the intensive care unit, a new study ... an improvement in mortality, so that adds to the ...
... WEST BLOOMFIELD, Mich., Nov. 20 Kelle Ilitch, an,entrepreneur ... metro-Detroit at her new studio and boutique, Pure Element ... Barre,Intensity(R). It uses a combination of weights, Pilates and ... body. The intense style barre,workout isn,t available at any ...
... is one of only five organizations in,nation to receive ... President,George W. Bush and Commerce Secretary Carlos Gutierrez ... receive the 2007 Malcolm,Baldrige National Quality Award, the nation,s ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071120/DC07985-a ...
Other Medicine News:Health News:S.C. BlueCross BlueShield Receives URAC Case Management Accreditation 2Health News:Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests 2Health News:Rapid Response Teams Can Save Hospitalized Kids 2Health News:Rapid Response Teams Can Save Hospitalized Kids 3Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 2Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 3Health News:Sharp HealthCare Receives 2007 Presidential Award for Quality and Performance Excellence 2Health News:Sharp HealthCare Receives 2007 Presidential Award for Quality and Performance Excellence 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: